An Overview of Pharmacopoeial Status of Ayurvedic, Unani and Siddha Drugs

Autores

  • Rajeev Kr. Sharma Director, Pharmacopoeial Laboratory for Indian Medicine, Department of AYUSH, Ministry of Health & Family Welfare, (Govt. of India), (OPP. M-BLOCK, SECTOR-23), KAMLA NEHRU NAGAR, GHAZIABAD-201002

Palavras-chave:

Pharmacopoeia, formularies, Ayurveda, Unani and Siddha system of medicine

Resumo

 Ayurvedic, Unani and Siddha Pharmacopoeia are part of regulatory framework of Drugs & Cosmetics Act, 1940. In these pharmacopoeia, single drugs (plant, mineral and metal origin) and classical compound formulations are incorporated to provide statutory standards. Ayurvedic Pharmacopoeia of India Part I (Vols. I–VIII) consists of 590 monographs on single drugs (plant, mineral, metal and extracts) and Part II (Vols. I–III) consists of 152 monographs on ayurvedic classical formulations. Unani Pharmacopoeia of India, Part I (Vols. I–VI) covers 298 single plant origin drugs and Pt-II (Vol. I and II) refers to 100 Unani classical formulations. Siddha Pharmacopoeia of India, Part-I published in two volumes provides specifications on 139 single drugs of plant origin. 

Biografia do Autor

  • Rajeev Kr. Sharma, Director, Pharmacopoeial Laboratory for Indian Medicine, Department of AYUSH, Ministry of Health & Family Welfare, (Govt. of India), (OPP. M-BLOCK, SECTOR-23), KAMLA NEHRU NAGAR, GHAZIABAD-201002
    Director,Pharmacopoeial Laboratory for Indian Medicine,Department of AYUSH, Ministry of Health & Family Welfare, (Govt. of India),(OPP. M-BLOCK, SECTOR-23),KAMLA NEHRU NAGAR,GHAZIABAD-201002

Downloads

Publicado

2012-02-16

Edição

Vol. 2 N.º 2 (2011)

Secção

Review Articles

Licença

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.